Want to join the conversation?
$VAL's net sales in Paints segment for 3Q16 rose slightly from last year. This includes effects of foreign currency translation that negatively impacted sales by 2%. Acquisitions added 4% to net sales in 3Q16. Volume increased 3%. Adjusted EBIT grew 30% on benefits from productivity initiatives and impact of Quest acquisition.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.